Department of Internal Medicine/Infectious Diseases, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Institute for Infection and Immunity, St George's, University of London, London, WC1E 7HU, UK; Section of Infectious Diseases & Immunity, Imperial College London, London, UK.
Travel Med Infect Dis. 2019 Jan-Feb;27:33-38. doi: 10.1016/j.tmaid.2018.10.011. Epub 2018 Oct 16.
Migrants may be underimmunised and at higher risk of vaccine-preventable diseases, yet there has been no comprehensive examination of what policies are currently implemented across Europe targeting child and adult migrants. We analysed vaccination policies for migrants in 32 EU/EEA countries and Switzerland.
Using framework analysis, we did a comparative analysis of national policies and guidelines pertaining to vaccination in recently arrived migrants through a systematic guideline and literature review and by approaching national experts.
Six (18.8%) of 32 countries had comprehensive policies specific to the vaccination of migrants (two focused only on child migrants, four on both adults and children). Nineteen (59.4%) countries applied their national vaccination schedule for migrant vaccinations, predominantly focusing on children; and five (15.6%) countries had circulated additional migrant-specific resources to relevant health-care providers. In six (18.8%) countries, policies on migrant vaccination focused on outbreak-specific vaccines only. In ten (31.3%) countries, policies focused on priority vaccinations, with polio being the vaccine most commonly administered and heterogeneity noted in vaccines recommended to adults, adolescents, and children. Eighteen (56.3%) countries recommended that an individual should be considered as unvaccinated where vaccination records were missing, and vaccines re-administered. Nine (28.1%) countries reported that specific vaccinations were mandatory.
There is considerable variation in policies across Europe regarding approaches to vaccination in adult and child migrants, and a lack of clarity on optimum ways forward, what vaccines to offer, with a need for robust research in this area. More emphasis must be placed on ensuring migrant-specific guidance is disseminated to front-line healthcare professionals to improve vaccine delivery and uptake in diverse migration populations across the region.
移民可能未充分免疫,并且更容易感染可通过疫苗预防的疾病,但目前尚未全面评估欧洲针对儿童和成年移民实施了哪些政策。我们分析了 32 个欧盟/欧洲经济区国家和瑞士针对移民的疫苗接种政策。
我们使用框架分析法,通过系统的指南和文献综述以及与国家专家联系,对新抵达移民的疫苗接种国家政策和指南进行了比较分析。
在 32 个国家中,有 6 个(18.8%)国家有专门针对移民疫苗接种的综合政策(其中 2 个仅针对儿童移民,4 个针对成人和儿童)。19 个(59.4%)国家采用其国家免疫计划为移民接种疫苗,主要针对儿童;5 个(15.6%)国家向相关卫生保健提供者分发了额外的移民特定资源。在 6 个(18.8%)国家,移民疫苗接种政策仅侧重于针对疫情的疫苗。在 10 个(31.3%)国家,政策侧重于优先疫苗接种,其中小儿麻痹症疫苗接种最为常见,并且建议为成人、青少年和儿童接种的疫苗存在差异。18 个(56.3%)国家建议,如果接种记录缺失,应将个人视为未接种疫苗,并重新接种疫苗。9 个(28.1%)国家报告称,某些疫苗接种是强制性的。
在针对成年和儿童移民的疫苗接种方法方面,欧洲各国的政策存在很大差异,对于最佳前进方向、应提供哪些疫苗缺乏明确性,因此该领域需要进行强有力的研究。必须更加重视确保向一线卫生保健专业人员传播针对移民的指导,以改善该地区不同移民群体的疫苗接种和接种率。